Annual report

Looking ahead, Penta is expanding its research horizon by strengthening the integration between basic science, translational research and clinical trials. Over recent years, the Foundation has worked with partners to…

Neonatal sepsis remains a leading cause of newborn mortality across Africa, requiring not only effective antibiotic treatments but also research that is grounded in the needs and realities of families.

In 2025, Penta reached a key milestone by strengthening frontline capacity in paediatric HIV care through the THRIVE Advanced HIV Disease training in Mozambique. Delivered in Maputo in September,

This article was written by Michael Davis Tira, Computer Security Incident Response Team (CSIRT) Representative, Data & Infrastructure Team Manager, and Silvia Cavallo,

Historically, pregnant individuals and infants have been routinely excluded from clinical research under the guise of protection. The PIPELINE project serves as a critical response to this systemic gap, reframing…

In 2025, Penta concluded the VERDI project, a major European collaboration launched to understand the impact of SARS‑CoV‑2 variants and mpox on children and pregnant people. Beyond its scientific outputs,

In 2025, Penta reached a major milestone with the completion of the EPPICC paediatric study on dolutegravir (DTG), a key antiretroviral medicine used in the treatment of children and adolescents…